LOADING
Author: eczemarelief
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis – Dermatology Times
October 28, 2024
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link
chat_bubble0 Comment
visibility160 Views
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis – Dermatology Times
October 26, 2024
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis Dermatology Times Source link
chat_bubble0 Comment
visibility165 Views
Eczema Awareness Month 2024: The Ecz-hibition – National Eczema Association
October 24, 2024
Eczema Awareness Month 2024: The Ecz-hibition National Eczema Association Source link
chat_bubble0 Comment
visibility169 Views
Study finds link between eczema and peripheral vascular disease – Medical Xpress
October 22, 2024
Study finds link between eczema and peripheral vascular disease Medical Xpress Source link
chat_bubble0 Comment
visibility157 Views